PDPN and psoriasis: In psoriasis, the effects of podoplanin on Th17 inflammation are controversial and further studies are required to elucidate the podoplanin-mediated cellular pathways that affect immune responses and, thus, the functional roles of podoplanin during the pathogenesis of psoriasis.